CYCN/ 01/06/2026 · 5:39 AM Cyclerion Partners with Medsteer to Advance Depression Treatment Cyclerion Therapeutics teams up with Medsteer to develop CYC-126, an innovative therapy for treatment-resistant depression, with Phase 2 trials starting in 2026.